KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CNTB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Connect Biopharma Holdings Ltd American
(Updated on Apr 26, 2024)

Sell candidate since Apr 22, 2024 Loss -0.74% PDF

The Connect Biopharma Holdings Ltd American stock price fell by -1.47% on the last day (Friday, 26th Apr 2024) from $1.36 to $1.34. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 7.69% from a day low at $1.30 to a day high of $1.40. The price has fallen in 7 of the last 10 days and is down by -22.09% for this period. Volume has increased on the last day by 24 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 58 thousand shares were bought and sold for approximately $77.89 thousand.

Given the current short-term trend, the stock is expected to rise 36.63% during the next 3 months and, with a 90% probability hold a price between $1.83 and $3.27 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CNTB Signals & Forecast

There are few to no technical positive signals at the moment. The Connect Biopharma Holdings Ltd American stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.41 and $1.54. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -39.09%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Connect Biopharma Holdings Ltd American gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Connect Biopharma Holdings Ltd American stock

Connect Biopharma Holdings Ltd American finds support from accumulated volume at $1.33 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.1000 between high and low, or 7.69%. For the last week, the stock has had daily average volatility of 10.43%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CNTB) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Connect Biopharma Holdings Limited American Depositary Shares to open at $1.35, and during the day (based on 14 day Average True Range), to move between $1.13 and $1.55, which gives a possible trading interval of +/-$0.208 (+/-15.51%) up or down from last closing price. If Connect Biopharma Holdings Limited American Depositary Shares takes out the full calculated possible swing range there will be an estimated 31.02% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.33 (0.75%) than the resistance at $1.36 (1.49%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Connect Biopharma Holdings Limited American Depositary Shares stock A Buy?

The Connect Biopharma Holdings Ltd American stock holds several negative signals and despite the positive trend, we believe Connect Biopharma Holdings Ltd American will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.044 Sell Candidate Unchanged

Predicted Opening Price for Connect Biopharma Holdings Limited American Depositary Shares of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$1.35 ( 0.498%) $1.34

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CNTB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.45 7.96 %
R2 1.41 5.11 %
R1 1.38 3.35 %
Current price: 1.34
Support S1 1.31 -2.35 %
S2 1.28 -4.11 %
S3 1.25 -6.97 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.61 20.15 %
R2 1.40 4.48 %
R1 1.36 1.49 %
Current price 1.34
Support S1 1.33 -0.746%
S2 1.24 -7.84%
S3 1.12 -16.42%

FAQ

What is the symbol for Connect Biopharma Holdings Limited American Depositary Shares Stock and on which exchange is it traded?
The symbol for Connect Biopharma Holdings Limited American Depositary Shares is CNTB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Connect Biopharma Holdings Limited American Depositary Shares Stock?
The Connect Biopharma Holdings Ltd American stock holds several negative signals and despite the positive trend, we believe Connect Biopharma Holdings Ltd American will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Connect Biopharma Holdings Limited American Depositary Shares Stock?
Connect Biopharma Holdings Limited American Depositary Shares Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Connect Biopharma Holdings Limited American Depositary Shares Stock.

What's the current price of Connect Biopharma Holdings Limited American Depositary Shares Stock?
As of the end of day on the Apr 26, 2024, the price of an Connect Biopharma Holdings Limited American Depositary Shares (CNTB) share was $1.34.

What is the 52-week high and low for Connect Biopharma Holdings Limited American Depositary Shares Stock?
The 52-week high for Connect Biopharma Holdings Limited American Depositary Shares Stock is $2.84 and the 52-week low is $0.550.

What is the market capitalization of Connect Biopharma Holdings Limited American Depositary Shares Stock?
As of the Apr 26, 2024, the market capitalization of Connect Biopharma Holdings Limited American Depositary Shares is 73.838M.
Click to get the best stock tips daily for free!

About Connect Biopharma Holdings Limited American Depositary Shares

Connect Biopharma Holdings Limited American Depositary Shares Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosin... CNTB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT